Oklahoma City Thunder guard Nikola Topic (44) drives up the court against the Charlotte Hornets during a preseason game on Oct. 5, 2025.

Oklahoma City Thunder guard Nikola Topic is undergoing chemotherapy treatment after being diagnosed with testicular cancer.

Thunder general manager Sam Presti told reporters of Topic's condition, saying that doctors are "extremely positive" for his long-term health.

The Thunder had announced earlier this month that Topic would be reevaluated in four to six weeks after undergoing a testicular procedure.

Topic, a 20-year-old from Serbia, missed the entire 2024-25 season with a torn ACL, after Oklahoma City selected him with the No. 12 overall pick in the 2024 draft.

Presti also said that Topic had a biopsy in October at the MD Anderson Cancer Center in Houston, and after getting the results, asked the team not to disclose his condition until after he started chemotherapy.

"Our only expectations for him are to focus on this," Presti said. "This is his most important priority. He'll be back playing basketball when he's able to, but we're not putting any time length or expectations on that, obviously. He has our total support, encouragement and love."

This article originally appeared on USA TODAY: Thunder guard Nikola Topic undergoing chemotherapy for testicular cancer

Reporting by Scooby Axson, USA TODAY / USA TODAY

USA TODAY Network via Reuters Connect